Inke
Marc L. is a Senior Scientist Project Lead at Inke since June 2022, specializing in the synthesis of active ingredients and organic synthesis experiments. Previously, Marc served as Project Leader CDMO at UQUIFA, where responsibilities included optimizing manufacturing processes for active pharmaceutical ingredients while ensuring safety and environmental standards. A Process Chemist at Moehs Iberica from April 2009 to June 2020, Marc focused on improving manufacturing efficiency and scaling processes from laboratory to industrial settings. Additional experience includes roles as a Synthetic Chemist and Scientific Assistant in medicinal chemistry, as well as a Scientist at the Consejo Superior de Investigaciones Científicas. Marc holds a Bachelor of Chemistry from Universitat de Barcelona, an MSc in Chemistry from Consejo Superior de Investigaciones Científicas, and a project management certification from Universitat Oberta de Catalunya.
This person is not in any teams
This person is not in any offices
Inke
At Inke S.A. we are dedicated to the development and manufacture of high-quality APIs, specializing in complex synthesis processes, particularly for respiratory therapies. With over 25 years of experience in micronisation and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. We are a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Our commitment to quality and regulatory excellence is reflected in our successful inspections by major global authorities, including the US-FDA, with our most recent inspection in April 2019. Our portfolio reflects our deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. We develop, patent, and implement own synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for our customers. In addition to our micronisation expertise, we provide comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Our R&D initiatives and advanced laboratory facilities make us a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs. To learn more about our expertise in inhalation therapies, please get in touch with us by sending an email to contact-inke@inke.es